Construction of Differential MRNA-lncRNA Crosstalk Networks Based on CeRNA Hypothesis Uncover Key Roles of LncRNAs Implicated in Esophageal Squamous Cell Carcinoma

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Dec 15

PMID 27966444

Citations 56

Authors

Shuang Yang

Qianqian Ning

Guobin Zhang

Hong Sun

Zhen Wang

Yixue Li

Affiliations

Soon will be listed here.

Abstract

Increasing evidence has indicated that lncRNAs acting as competing endogenous RNAs (ceRNAs) play crucial roles in tumorigenesis, metastasis and diagnosis of cancer. However, the function of lncRNAs as ceRNAs involved in esophageal squamous cell carcinoma (ESCC) is still largely unknown. In this study, clinical implications of two intrinsic subtypes of ESCC were identified based on expression profiles of lncRNA and mRNA. ESCC subtype-specific differential co-expression networks between mRNAs and lncRNAs were constructed to reveal dynamic changes of their crosstalks mediated by miRNAs during tumorigenesis. Several well-known cancer-associated lncRNAs as the hubs of the two networks were firstly proposed in ESCC. Based on the ceRNA mechanism, we illustrated that the"loss" of miR-186-mediated PVT1-mRNA and miR-26b-mediated LINC00240-mRNA crosstalks were related to the two ESCC subtypes respectively. In addition, crosstalks between LINC00152 and EGFR, LINC00240 and LOX gene family were identified, which were associated with the function of "response to wounding" and "extracellular matrix-receptor interaction". Furthermore, functional cooperation of multiple lncRNAs was discovered in the two differential mRNA-lncRNA crosstalk networks. These together systematically uncovered the roles of lncRNAs as ceRNAs implicated in ESCC.

Citing Articles

Development of a tertiary lymphoid structure-based prognostic model for breast cancer: integrating single-cell sequencing and machine learning to enhance patient outcomes.

Zhang X, Li L, Shi X, Zhao Y, Cai Z, Ni N Front Immunol. 2025; 16:1534928.

PMID: 40078998 PMC: 11897234. DOI: 10.3389/fimmu.2025.1534928.

H19: An Oncogenic Long Non-coding RNA in Colorectal Cancer.

Chowdhury P, Salvamani S, Gunasekaran B, Peng H, Ulaganathan V Yale J Biol Med. 2024; 96(4):495-509.

PMID: 38161577 PMC: 10751868. DOI: 10.59249/TDBJ7410.

Machine learning multi-omics analysis reveals cancer driver dysregulation in pan-cancer cell lines compared to primary tumors.

Sanders L, Chandra R, Zebarjadi N, Beale H, Lyle A, Rodriguez A Commun Biol. 2022; 5(1):1367.

PMID: 36513728 PMC: 9747808. DOI: 10.1038/s42003-022-04075-4.

lncRNA PVT1: a novel oncogene in multiple cancers.

Li R, Wang X, Zhu C, Wang K Cell Mol Biol Lett. 2022; 27(1):84.

PMID: 36195846 PMC: 9533616. DOI: 10.1186/s11658-022-00385-x.

LINC00240/miR-155 axis regulates function of trophoblasts and M2 macrophage polarization via modulating oxidative stress-induced pyroptosis in preeclampsia.

Wu H, Liu K, Zhang J Mol Med. 2022; 28(1):119.

PMID: 36153499 PMC: 9509611. DOI: 10.1186/s10020-022-00531-3.

References

Sunpaweravong P, Sunpaweravong S, Puttawibul P, Mitarnun W, Zeng C, Baron A . Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2005; 131(2):111-9. DOI: 10.1007/s00432-004-0610-7. View

Hanawa M, Suzuki S, Dobashi Y, Yamane T, Kono K, Enomoto N . EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus. Int J Cancer. 2005; 118(5):1173-80. DOI: 10.1002/ijc.21454. View

Rouvelas I, Zeng W, Lindblad M, Viklund P, Ye W, Lagergren J . Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol. 2005; 6(11):864-70. DOI: 10.1016/S1470-2045(05)70347-8. View

Lacouture M . Mechanisms of cutaneous toxicities to EGFR inhibitors. Nat Rev Cancer. 2006; 6(10):803-12. DOI: 10.1038/nrc1970. View

Lyng H, Brovig R, Svendsrud D, Holm R, Kaalhus O, Knutstad K . Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics. 2006; 7:268. PMC: 1626467. DOI: 10.1186/1471-2164-7-268. View

Hansen L, Laerum O, Illemann M, Nielsen B, Ploug M . Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma. Int J Cancer. 2007; 122(4):734-41. DOI: 10.1002/ijc.23082. View

Guan Y, Kuo W, Stilwell J, Takano H, Lapuk A, Fridlyand J . Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res. 2007; 13(19):5745-55. DOI: 10.1158/1078-0432.CCR-06-2882. View

Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X . miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 2008; 37(Database issue):D98-104. PMC: 2686559. DOI: 10.1093/nar/gkn714. View

Le Q, Harris J, Magliocco A, Kong C, Diaz R, Shin B . Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03. J Clin Oncol. 2009; 27(26):4281-6. PMC: 2744270. DOI: 10.1200/JCO.2008.20.6003. View

10.

Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S . Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep. 2010; 23(6):1625-33. DOI: 10.3892/or_00000804. View

11.

de la Fuente A . From 'differential expression' to 'differential networking' - identification of dysfunctional regulatory networks in diseases. Trends Genet. 2010; 26(7):326-33. DOI: 10.1016/j.tig.2010.05.001. View

12.

Poliseno L, Salmena L, Zhang J, Carver B, Haveman W, Pandolfi P . A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010; 465(7301):1033-8. PMC: 3206313. DOI: 10.1038/nature09144. View

13.

Barker H, Chang J, Cox T, Lang G, Bird D, Nicolau M . LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res. 2011; 71(5):1561-72. PMC: 3842018. DOI: 10.1158/0008-5472.CAN-10-2868. View

14.

Liu M, Wang Z, Yang S, Zhang W, He S, Hu C . TNF-α is a novel target of miR-19a. Int J Oncol. 2011; 38(4):1013-22. DOI: 10.3892/ijo.2011.924. View

15.

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi P . A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell. 2011; 146(3):353-8. PMC: 3235919. DOI: 10.1016/j.cell.2011.07.014. View

16.

Yu H, Liu B, Ye Z, Li C, Li Y, Li Y . Link-based quantitative methods to identify differentially coexpressed genes and gene pairs. BMC Bioinformatics. 2011; 12:315. PMC: 3199761. DOI: 10.1186/1471-2105-12-315. View

17.

Meyer K, Maia A, OReilly M, Ghoussaini M, Prathalingam R, Porter-Gill P . A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression. PLoS Genet. 2011; 7(7):e1002165. PMC: 3140991. DOI: 10.1371/journal.pgen.1002165. View

18.

Li T, Xu L, Wu Z, Liao L, Shen J, Xu X . Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Hum Pathol. 2011; 43(7):1068-76. DOI: 10.1016/j.humpath.2011.07.027. View

19.

Ross S, McCord A, Jung C, Atan D, Mok S, Hemberg M . Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assembly. Neuron. 2012; 73(2):292-303. PMC: 3269007. DOI: 10.1016/j.neuron.2011.09.035. View

20.

Miles G, Seiler M, Rodriguez L, Rajagopal G, Bhanot G . Identifying microRNA/mRNA dysregulations in ovarian cancer. BMC Res Notes. 2012; 5:164. PMC: 3342161. DOI: 10.1186/1756-0500-5-164. View